Clinical Trial Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), Product & Services (Software), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021
[123 Pages Report] The overall market for clinical trial imaging is projected to reach $1069.7 billion by 2021 from $773.4 billion in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending by growing pharmaceutical and biotechnology industries is attributed to the growth of the market.
Objectives of the Study
- To define, describe, and segment the global market of clinical trial imaging on the basis of product and service, modality, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, regulatory approvals, and agreements in the market
Research Methodology
Both, top-down and bottom-up approaches were used to validate the size of the global market of clinical trial imaging and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market presence was studied through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, presentations, websites, and press releases of top players, news articles, journals; and paid databases ,white papers, medical journals, certified publications, articles from recognized authors, directories, and databases such as American College of Radiology (ACR), American Medical Association (AMA), Digital Imaging and Communication in Medicine (DICOM), European Association of Nuclear Medicine (EANM), International Consortium for Medical Imaging Technology (ICMIT), North American Society for Cardiovascular Imaging (NASCI), National Cancer Institute (NCI), Society of Nuclear Medicine and Molecular Imaging (SNMMI). Whereas, primary research included extensive interviews with key opinion leaders such as CEOs, vice presidents, directors, marketing executives, and related key executives from various companies. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.
To know about the assumptions considered for the study, download the pdf brochure
Target Audience:
- Medical Device Industries
- Academic and Government Research Institutes
- Diagnostic Centers
- Market Research and consulting firms
- Pharmaceutical and biotechnology manufacturers
- Contract research organizations (CROs)
- Contract manufacturing organizations (CMOs)
- Clinical Trial Imaging Manufacturers, Vendors, and Distributors
Scope of the Report
The research report categorizes the global market of clinical trial imaging into the following segments and subsegments:
By Product and Service
- Services
- Software
By Modality
- Computed Tomography
- Magnetic Resonance Imaging
- Positron Emission Tomography
- Ultrasound
- X-Ray
- Echocardiography
- Other Modalities (Magnetic Resonance Elastography and Dual-energy x-ray Absorptiometry)
By End User
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Manufacturers
- Contract Research Organizations
- Academic and Government Research Institutes
- Other End Users (Cosmetics & skin care industries)
By Region
- North America
- US
- Canada
- Europe
- Asia
- Rest of the World (RoW)
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Detailed analysis of market in European countries such as the UK, Germany, France, Italy, Spain, and others
- Detailed analysis of market in Asia Pacific countries such as China, Japan, India, and others
The global market is projected to reach $1069.7 billion by 2021 from $773.4 billion in 2016, at a CAGR of 6.7% from 2016 to 2021. Clinical trial imaging is used to create images of the human body for clinical purposes to reveal, diagnose, or examine diseases. Imaging testing is mainly done using X-rays, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), and echocardiography (ECHO). In clinical trial, imaging is used primarily to evaluate efficacy end-points and more frequently, for safety evaluations and/or eligibility criteria. Growth in this market will largely be driven by the increase in R&D spending and growth in the pharmaceutical and biotechnology industries and the increasing number of contract research organizations.
In this report, the global market is broadly segmented by product and service, modality, end user, and region.
The global market is broadly segmented into service and software. The services segment is expected to hold the largest share of the market in 2016, and grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the increased outsourcing of imaging clinical trials by pharmaceutical, biotechnology, and medical device companies to CROs will drive the growth of the services segment.
Based on the modality, the market is segmented into CT, MRI, PET, ultrasound, ECHO, x-ray, and other modalities (such as magnetic resonance elastography (MRE) and dual-energy X-ray absorptiometry (DXA)). The positron emission tomography (PET) segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the increasing usage of PET in clinical trials for screening various organs to obtain information about the function and metabolism.
On the basis of end user, the market is categorized into pharmaceutical companies, biotechnology companies, medical device manufacturers, contract research organizations, academic and government research institutes, and other end users (cosmetics and skin care companies). Medical device manufacturers segment is expected to grow at a highest CAGR during the forecast period. Increased R&D spending by medical device manufacturers and the growing medical devices market are factors contributing to the high growth of this end-user segment
Geographically, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR in the forecast period. The growth in the Asian clinical trial imaging market is driven by the growth in pharmaceutical & biotechnology industries and increase in R&D spending in the region.
However, high competition among major players, which acts as an entry barrier for new entrants, and high implementation costs of imaging systems are restraining the growth of this market.
The key players in the global clinical trial imaging market are BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), BioTelemetric, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.). These players focus on inorganic and organic strategies such as greements, collaborations, and partnerships, expansions, acquisitions to sustain their growth in the global market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 14)
1.1 Objectives of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in The Study
1.4 Currency
1.5 Limitation
1.6 Stakeholders
2 Research Methodology (Page No. - 17)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Rank Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Key Industry Insights
2.3.4 Assumptions for The Study
3 Executive Summary (Page No. - 24)
4 Premium Insights (Page No. - 27)
4.1 Clinical Trial Imaging: Market Overview
4.2 By Product & Service, 2016
4.3 Market Size, By Modality, 2016 vs 2021
4.4 Market Size, By End User, 2016 vs 2021
4.5 Geographic Snapshot of The Market
4.6 Life Cycle Analysis, By Region
5 Market Overview (Page No. - 32)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in R&D Spending
5.2.1.2 Growth in The Pharmaceutical and Biotechnology Industries
5.2.1.3 Increasing Number of Cros
5.2.2 Restraints
5.2.2.1 High Implementation Cost of Imaging Systems
5.2.3 Opportunities
5.2.3.1 Emerging Economies
5.2.3.2 Development of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, and Radiopharmaceuticals
5.2.4 Challenges
5.2.4.1 High Cost of Clinical Trials
5.2.4.2 High Cost of Pet
5.3 Recent Market Trends
5.3.1 Rising Demand for Multimodality Imaging Technology in Clinical Trials
5.4 Regulatory Scenario
5.5 Clinical Trials: Global Scenario
6 Global Market, By Product and Service (Page No. - 39)
6.1 Introduction
6.2 Services
6.2.1 Operational Imaging Services
6.2.2 Read Analysis Services
6.2.3 System and Technical Support Services
6.2.4 Trial Design Consulting Services
6.3 Software
7 Global Market, By Modality (Page No. - 48)
7.1 Introduction
7.2 Computed Tomography
7.3 Magnetic Resonance Imaging
7.4 Ultrasound
7.5 Positron Emission Tomography
7.6 X-Ray
7.7 Echocardiography
7.8 Other Modalities
8 Global Market, By End User (Page No. - 57)
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Biotechnology Companies
8.4 Medical Device Manufacturers
8.5 Contract Research Organizations
8.6 Academic and Government Research Institutes
8.7 Other End Users
9 Global Market, By Region (Page No. - 68)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.5 Rest of The World (RoW)
10 Competitive Landscape (Page No. - 89)
10.1 Introduction
10.2 Strategic Overview
10.3 Competitive Situation and Trends
10.4 Leading Players in The Market
10.4.1 Agreements, Collaborations, and Partnerships
10.4.2 Expansion
10.4.3 Acquisition
10.4.4 Product and Service Launches & Product Upgrades
11 Company Profiles (Page No. - 95)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Bioclinica, Inc.
11.3 Parexel International Corporation
11.4 Icon PLC
11.5 Biomedical Systems Corporation
11.6 Biotelemetry, Inc.
11.7 Cardiovascular Imaging Technologies, LLC
11.8 Intrinsic Imaging LLC
11.9 Ixico PLC
11.10 Radiant Sage LLC
11.11 Worldcare Clinical, LLC
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 112)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Knowledge Store: Marketsandmarkets Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports
12.8 Author Details
List of Tables (77 Tables)
Table 1 Phases of Clinical Trials
Table 2 Global Scenario of Clinical Trials Till 2015
Table 3 Market Size, By Product and Service, 20142021 (USD Million)
Table 4 Clinical Trial Imaging Services Market Size, By Type, 20142021 (USD Million)
Table 5 Clinical Trial Imaging Services Market Size, By Region, 20142021 (USD Million)
Table 6 North America: Clinical Trial Imaging Services Market Size, By Country, 20142021 (USD Million)
Table 7 Operational Imaging Services Market Size, By Region, 20142021 (USD Million)
Table 8 North America: Operational Imaging Services Market Size, By Country, 20142021 (USD Million)
Table 9 Read Analysis Services Market Size, By Region, 20142021 (USD Million)
Table 10 North America: Read Analysis Services Market Size, By Country, 20142021 (USD Million)
Table 11 System and Technical Support Services Market Size, By Region, 20142021 (USD Million)
Table 12 North America: System and Technical Support Services Market Size, By Country, 20142021 (USD Million)
Table 13 Trial Design Consulting Services Market Size, By Region, 20142021 (USD Million)
Table 14 North America: Trial Design Consulting Services Market Size, By Country, 20142021 (USD Million)
Table 15 Clinical Trial Imaging Software Market Size, By Region, 20142021 (USD Million)
Table 16 North America: Clinical Trial Imaging Software Market Size, By Country, 20142021 (USD Million)
Table 17 Market Size, By Modality, 20142021 (USD Million)
Table 18 Market Size for CT, By Region, 20142021 (USD Million)
Table 19 North America: Market Size for CT, By Country, 20142021 (USD Million)
Table 20 Market Size for Mri, By Region, 20142021 (USD Million)
Table 21 North America: Market Size for Mri, By Country, 20142021 (USD Million)
Table 22 Market Size for Ultrasound, By Region, 20142021 (USD Million)
Table 23 North America: Market Size for Ultrasound, By Country, 20142021 (USD Million)
Table 24 Market Size for Pet, By Region, 20142021 (USD Million)
Table 25 North America: Market Size for Pet, By Country, 20142021 (USD Million)
Table 26 Market Size for X-Ray, By Region, 20142021 (USD Million)
Table 27 North America: Market Size for X-Ray, By Country, 20142021 (USD Million)
Table 28 Market Size for Echocardiography, By Region, 20142021 (USD Million)
Table 29 North America: Market Size for Echocardiography, By Country, 20142021 (USD Million)
Table 30 Market Size for Other Modalities, By Region, 20142021 (USD Million)
Table 31 North America: Market Size for Other Modalities, By Country, 20142021 (USD Million)
Table 32Market Size, By End User, 20142021 (USD Million)
Table 33 Market Size, By Region, 20142021 (USD Million)
Table 34 North America: Market Size, By Country, 20142021 (USD Million)
Table 35 Market Size for Pharmaceutical Companies, By Region, 20142021 (USD Million)
Table 36 North America: Market Size for Pharmaceutical Companies, By Country, 20142021 (USD Million)
Table 37 Market Size for Biotechnology Companies, By Region, 20142021 (USD Million)
Table 38 North America: Market Size for Biotechnology Companies, By Country, 20142021 (USD Million)
Table 39 Market Size for Medical Device Manufacturers, By Region, 20142021 (USD Million)
Table 40 North America: Market Size for Medical Device Manufacturers, By Country, 20142021 (USD Million)
Table 41 Market Size for Contract Research Organizations, By Region, 20142021 (USD Million)
Table 42 North America: Market Size for Contract Research Organizations , By Country, 20142021 (USD Million)
Table 43 Market Size for Academic and Government Research Institutes, By Region, 20142021 (USD Million)
Table 44 North America: Market Size for Academic and Government Research Institutes, By Country, 20142021 (USD Million)
Table 45 Market Size for Other End Users, By Region, 20142021 (USD Million)
Table 46 North America: Market Size for Other End Users, By Country, 20142021 (USD Million)
Table 47 Market Size, By Region, 20142021 (USD Million)
Table 48 North America: Market Size, By Country, 20142021 (USD Million)
Table 49 North America: Market Size, By Product & Service, 20142021 (USD Million)
Table 50 North America: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 51 North America: Market Size, By Modality, 20142021 (USD Million)
Table 52 North America: Market Size, By End User, 20142021 (USD Million)
Table 53 U.S.: Market Size, By Product & Service, 20142021 (USD Million)
Table 54 U.S.: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 55 U.S.: Market Size, By Modality, 20142021 (USD Million)
Table 56 U.S.: Market Size, By End User, 20142021 (USD Million)
Table 57 Canada: Market Size, By Product & Service, 20142021 (USD Million)
Table 58 Canada: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 59 Canada: Market Size, By Modality, 20142021 (USD Million)
Table 60 Canada: Market Size, By End User, 20142021 (USD Million)
Table 61 Europe: Market Size, By Product & Service, 20142021 (USD Million)
Table 62 Europe: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 63 Europe: Market Size, By Modality, 20142021 (USD Million)
Table 64 Europe: Market Size, By End User, 20142021 (USD Million)
Table 65 Asia: Market Size, By Product & Service, 20142021 (USD Million)
Table 66 Asia: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 67 Asia: Market Size, By Modality, 20142021 (USD Million)
Table 68 Asia: Market Size, By End User, 20142021 (USD Million)
Table 69 RoW: Market Size, By Product & Service, 20142021 (USD Million)
Table 70 RoW: Clinical Trial Imaging Services Market Size, By Type, 2014-2021 (USD Million)
Table 71 RoW: Market Size, By Modality, 20142021 (USD Million)
Table 72 RoW: Market Size, By End User, 20142021 (USD Million)
Table 73 Rank of Companies in The Global Market, 2015
Table 74 Agreements, Collaborations, and Partnerships, 20132016
Table 75 Expansions, 20132016
Table 76 Acquisitions, 20132016
Table 77 Product and Service Launches & Product Upgrades, 20132016
List of Figures (32 Figures)
Figure 1 Market Segmentation
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Market Size, By Product & Service, 2016 vs 2021 (USD Million)
Figure 8 Market Size, By Modality, 2016 vs 2021 (USD Million)
Figure 9 Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 10 Geographic Snapshot of The Market
Figure 11 Emerging Economies Offer Significant Growth Opportunities for Players in The Market
Figure 12 Services Segment to Account for The Largest Share of The Market in 2016
Figure 13 Pet Modality Segment to Register The Highest CAGR During The Forecast Period
Figure 14 Pharmaceutical Companies to Account for The Largest Market Share in 2016
Figure 15 Asia to Register The Highest Growth Rate From 2016 to 2021
Figure 16 Asia Offers Significant Growth Opportunities in The Forecast Period
Figure 17 Increase in R&D Spending Will Drive The Growth of The Market
Figure 18 Clinical Trial Imaging Services to Form The Largest Segment in 2016
Figure 19 CT Segment to Dominate The Market in 2016
Figure 20 Pharmaceutical Companies to Account for The Largest Share of The Market in 2016
Figure 21 Number of Biotechnology and Pharmaceutical Patents Granted in 2012, By Region
Figure 22 North America to Dominate The Market During The Forecast Period
Figure 23 Clinical Trial Imaging Market in Asia Expected to Grow at The Highest Rate During The Forecast Period
Figure 24 North America: Market Snapshot
Figure 25 Asia: Market Snapshot
Figure 26 Agreements, Partnerships, and Collaborations is The Key Growth Strategy Adopted By Players in The Clinical Trial Imaging Market
Figure 27 Battle for Market Share: Agreements, Collaborations, and Partnerships: The Key Strategies Adopted By Players Between January 2013 and October 2016
Figure 28 Geographic Revenue Mix of The Top Three Market Players
Figure 29 Company Snapshot: Parexel International Corporation
Figure 30 Company Snapshot: Icon PLC
Figure 31 Company Snapshot: Biotelemetry, Inc.
Figure 32 Company Snapshot: Ixico PLC
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Clinical Trial Imaging Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Clinical Trial Imaging Market